Nyt fra tidsskrifterne
Søgeord (phase 3) valgt.
13 emner vises.
1
Effectiveness and safety of shortened intensive treatment for children with tuberculous meningitis (SURE): a protocol for a phase 3 randomised controlled trial evaluating 6 months of antituberculosis therapy and 8 weeks of aspirin in Asian and African children with tuberculous meningitis
BMJ Open
Tilføjet 3.04.2025
2
[Articles] Vaccine efficacy of NVX-CoV2373 against SARS-CoV-2 infection in adolescents in the USA: an ancillary study to a phase 3, observer-blinded, randomised, placebo-controlled trial
Lancet Microbe
Tilføjet 1.04.2025
3
[Articles] Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine targeting serogroups A, C, W, Y, and X when co-administered with routine childhood vaccines at ages 9 months and 15 months in Mali: a single-centre, double-blind, randomised, controlled, phase 3, non-inferiority trial
Lancet
Tilføjet 28.03.2025
4
[Articles] Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9–14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trial
Lancet Infectious Diseases
Tilføjet 20.03.2025
5
Estimated Efficacy of TAK-003 Against Asymptomatic Dengue Infection in Children/Adolescents Participating in the DEN-301 Trial in Asia Pacific and Latin America
Journal of Infectious Diseases
Tilføjet 19.03.2025
6
Doravirine/islatravir (100/0.75 mg) once-daily compared to bictegravir/emtricitabine/tenofovir alafenamide as initial HIV-1 treatment: 48-week results from a phase 3, randomized, controlled, double-blind, non-inferiority trial
Clinical Infectious Diseases
Tilføjet 14.03.2025
7
CADOR (Capsaicin in neuropathic-like pain in digital osteoarthritis) study protocol: a multicentre randomised parallel-group trial
BMJ Open
Tilføjet 7.03.2025
8
Long-term safety and efficacy of anti-GM-CSF otilimab in patients with rheumatoid arthritis: long-term extension of three phase 3 randomised trials (contRAst X)
BMJ Open
Tilføjet 6.03.2025
9
[Articles] Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials
Lancet Respiratory Medicine
Tilføjet 5.03.2025
10
Efficacy and Safety of the Two-Drug Regimen Dolutegravir/Lamivudine in Adolescents Living With HIV-1 Naive to Antiretroviral Therapy at 48 Weeks (DANCE): A Single-Arm, Open-label, Phase 3b Trial
Journal of Acquired Immune Deficiency Syndromes
Tilføjet 28.02.2025
11
[Articles] Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trial
Lancet Infectious Diseases
Tilføjet 25.02.2025
12
Protocol to establish standards for the elements infection prevention and control programs and competencies for infection control professionals in Australian residential aged care homes
PLoS One Infectious Diseases
Tilføjet 25.02.2025
13
Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial
Clinical Infectious Diseases
Tilføjet 17.02.2025